This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Lei-Ron Jan: Innovator in Flavivirus Vaccine Development
Introduction
Lei-Ron Jan is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines against flavivirus infections. His work focuses on enhancing the immunogenicity of viral envelope proteins, which is crucial for effective vaccine formulation.
Latest Patents
Lei-Ron Jan holds a patent for a C-terminally truncated dengue and Japanese encephalitis virus envelope. This invention relates to flavivirus envelope proteins that are 80-81% in size compared to their full-length counterparts. These truncated proteins are more immunogenic, making them valuable for vaccine development. The patent also covers recombinant viruses that encode the truncated protein and host cells that express and secrete this protein, which can be utilized in vaccine formulations.
Career Highlights
Jan works for the United States of America as Represented by the Department of Health. His role involves research and development aimed at combating flavivirus infections through innovative vaccine strategies. His expertise in virology and immunology has positioned him as a key figure in this area of research.
Collaborations
Lei-Ron Jan has collaborated with notable colleagues, including Ruhe Men and Michael Bray. These partnerships have facilitated advancements in vaccine research and development, contributing to the overall progress in the field.
Conclusion
In summary, Lei-Ron Jan is a distinguished inventor whose work on flavivirus vaccines has the potential to significantly impact public health. His innovative approaches to vaccine development highlight the importance of research in combating viral infections.